Author

Sang‐Bae Yoo

Observed names: S Y Yoo, S. Y. Yoo, Sang-Bae Yoo

Institution: The Genetics Society of Korea

Observed institutions: The University of Texas MD Anderson Cancer Center, The Genetics Society of Korea, Gangneung Asan Hospital

ORCID: 0000-0002-5210-8182

Observed ORCID: 0000-0002-5210-8182

OpenAlex ID: A5086856714

A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia

2019 · C. W. Hu, Y. Qiu, et al. · Nature Biomedical Engineering · 44

Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target

2016 · G Alatrash, H R Garber, et al. · Leukemia · 35

Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo‐controlled trial in North East Asia

2023 · Chang‐Hee Suh, Yoonhee Lee, et al. · International Journal of Rheumatic Diseases · 10

Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post‐marketing surveillance

2023 · Kina Jeon, Sang‐Bae Yoo, et al. · Pharmacoepidemiology and Drug Safety · 4

A randomized multicenter double-blind placebo-controlled trial to evaluate the efficacy and safety of cilostazol in patients with vasospastic angina (STELLA trial)

2013 · J. H. Kim, E. S. Shin, et al. · European Heart Journal · 2

Safety and Effectiveness of Intravenous Belimumab in Patients with Systemic Lupus Erythematosus in South Korea: A Multicentre, Observational, Real-World Study

2026 · Sang-Bae Yoo, Jung-Eun Cho, et al. · Drugs - Real World Outcomes

Works count: 6

Citation count: 95

H-index: 4

I10-index: 3